Você procurou por: qawwi ta fuq (Maltês - Inglês)

[induttur qawwi ta’
[potent cyp450 inducer]

[induttur qawwi ta’ cyp450;
[potent cyp450 inducer; cyp3a4

attakk qawwi ta ’ l- epatite
exacerbations of hepatitis

ta’ inibitur qawwi ta’ cyp3a4.
potent cyp3a4 inhibitor.

indinavir hu inibitur qawwi ta’ cyp3a4.
indinavir is a potent cyp3a4 inhibitor.

clarithromycin (impeditur qawwi ta‟ cyp3a4/5)
clarithromycin (strong cyp3a4/5 inhibitor)

aggravar qawwi ta’ l-attakki ta’ l-ażma
severe asthma exacerbations

nisa li ma jovulawx minħabba nuqqas qawwi ta’ lh u fsh
women with anovulation resulting from severe lh and fsh deficiency

dan jinkludi wkoll komponent qawwi ta’ risistemazzjoni u rilokazzjoni.
this also includes a strong resettlement and relocation component.

dawn jistgħu iwasslu għal telf qawwi ta’ ilma (deidratazzjoni).
these can lead to severe loss of water (dehydration).

madwar il-mejda, kien hemm sens qawwi ta' qbil dwar dan.
around the table, there was a strong sense of agreement about this.

ketoconazole huwa inibitur qawwi ta’ cyp3a4 u tal-p-gp.
ketoconazole is a potent inhibitor of cyp3a4 and p-gp.

evita d-dawl tax-xemx dirett jew dawl qawwi ta’ ġewwa.
avoid direct sunlight or strong indoor lighting.

phenytoin (sostratt ta 'cyp2c9 u induttur qawwi ta' cyp450):
phenytoin (cyp2c9 substrate and potent cyp450 inducer):

għadd ta’episodji ta’ impuls qawwi ta’ inkontinenza kull 24 siegħa
number of urge incontinence episodes per 24 hours

bażi b’potenzjal qawwi ta’ aktar impjiegi ta’ kwalità aħjar;
a source of rich potential in terms of more, better jobs;

cobicistat hu impeditur qawwi ta’ cyp3a ibbażat fuq il-mekkaniżmu u hu wkoll substrat ta’ cyp3a.
cobicistat is a strong mechanism-based inhibitor of cyp3a and is also a cyp3a substrate.

ritonavir (induttur qawwi ta' cyp450; inibitur u substrat ta' cyp3a4)
ritonavir (potent cyp450 inducer; cyp3a4 inhibitor and substrate)

cobicistat hu impeditur qawwi ta’ cyp3a ibbażat fuq kif jagħmel l-effett tiegħu u hu substrat ta’ cyp3a.
cobicistat is a strong mechanism-based cyp3a inhibitor and is a cyp3a substrate.

fluvoxamine (100 mg darba kuljum), inibitur qawwi ta ’ cyp1a2, naqqas it -
fluvoxamine (100 mg once daily), a potent inhibitor of cyp1a2, decreased the apparent plasma clearance of duloxetine by about 77% and increased auc0-t 6-fold.